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The aim of this work was to validate the simple and rapid isocratic reversed phase-high
performance liquid chromatography using a C-18 column for the determination of cur-
cuminoid contents, dissolution profile, and volatile oil content of turmeric capsules pro-
duced at three secondary government hospitals. The validated reversed phase-high
performance liquid chromatography method for three curcuminoids (bisdemethox-
ycurcumin, demethoxycurcumin, and curcumin) had a good linearity (R2 > 0.9990), accu-
racy (% recovery was 99.96e101.14%, 97.42e102.23%, and 98.01e99.12% for
bisdemethoxycurcumin, demethoxycurcumin, and curcumin, respectively), precision (%
relative standard deviation < 2% and < 5% for intraday and interday precision, respec-
tively), including limit of detection, limit of quantitation, and system suitability. We found
that turmeric capsules had a higher content of curcumin than bisdemethoxycurcumin and
demethoxycurcumin. The total curcuminoid contents of all lots ranged from 12.02%w/w to
14.36%w/w. Dissolution profiles of curcuminoids were fitted with Higuchi model. Moreover,
volatile oil content, determined using the hydrodistillation method, ranged from 7.00%v/w
to 8.00%v/w. In conclusion, all nine lots of turmeric capsules from three secondary gov-
ernment hospitals met the standard criteria of the Thai Herbal Pharmacopoeia in the topic
of curcuminoid contents, dissolution, and volatile oil content.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).al Products Research an
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Turmeric or Curcuma longa L. (Zingiberaceae) is an edible and
herbaceous plant and has been used in Thai traditional
medicines for a long time due to its many pharmacological
activities. Turmeric rhizome contains curcuminoid com-
pounds (2e6%), volatile oil (3e7%), fiber (2e7%), mineral mat-
ter (3e7%), protein (6e8%), fat (5e10%), moisture (6e13%), and
carbohydrate (60e70%) [1]. The common volatile oils found in
turmeric rhizome are r-turmerone (38%), a-turmerone (19%),
and b-turmerone (15%) [2]. The major active compounds of
turmeric rhizome are curcuminoids including bisdemethox-
ycurcumin, demethoxycurcumin, and curcumin. The chemi-
cal structures of these three curcuminoids are shown in
Figure 1.
Turmeric rhizome powder had many pharmacological
effects such as the treatment of irritable bowel syndrome
[3], peptic ulcer [4], and inflammatory bowel disease [5].
There was a clinical trial in 2001 that studied 45 patients
with peptic ulcers [4]. The patients received 600 mg of
turmeric rhizome powder-filled capsules five times per day.
The results showed that the peptic ulcers in 19 patients were
absent within 12 weeks, peptic ulcers in 18 patients were
absent within 8 weeks, and peptic ulcers in 12 patients were
absent within 4 weeks. Results from blood chemistry and
hematology of all patients showed no significant difference
both before and after treatments [4]. Furthermore, in 2004,
turmeric rhizome extract was studied in 207 patients with
irritable bowel syndrome. They were administered one to
two tablets (72e144 mg) of turmeric rhizome extract for
8 weeks. Data showed that the prevalence of irritable bowel
syndrome decreased as well as abdominal pain and
discomfort score [3]. In addition, curcumin has anti-Heli-
cobacter pyroli activity. However, this effect has not yet been
clarified [6].Figure 1 e Chemical structure of curcumin, demeIn Thai traditional medicines, turmeric is used as an anti-
flatulent and for the treatment of peptic ulcers due to its
richness of volatile oil and curcuminoid content. A turmeric
rhizome powder-filled capsule is one of many official herbal
products in the 2013 National List of Essential Medicines
(Herbal Medicines) of Thailand [7]. Nowadays, turmeric cap-
sules are the most popular herbal products compared with
other herbal products. Moreover, some secondary govern-
ment hospitals produced turmeric capsules and dispensed
them to their patients. However, the quality control of this
herbal product is rarely evaluated. The determination of cur-
cuminoid contents, dissolution profiles, and volatile oil con-
tent of turmeric capsules is necessary to evaluate the quality
of turmeric capsules. The purpose of this studywas to validate
a simple and rapid reversed phase-high performance liquid
chromatography using a C-18 column in order to determine
the individual and total curcuminoid contents, as well as
dissolution profile of curcuminoids in turmeric capsules pro-
duced at some secondary government hospitals. In addition,
volatile oil content was investigated.2. Methods
2.1. Materials
Standard curcuminoids [ 98%, high performance liquid
chromatography (HPLC)] were purchased from Fluka Chem-
ika, Buch, Switzerland as a mixture of bisdemethox-
ycurcumin, demethoxycurcumin, and curcumin. Samples of
turmeric capsules (500 mg/capsule) were obtained from three
secondary government hospitals with three lots each. Hospi-
tals in the northern, the southern, and central Thailand were
represented as Hospital A, B, and C, respectively. Nine lots of
turmeric capsule samples that were produced within the
previous 3 months were included in this work. Sodium laurylthoxycurcumin, and bisdemethoxycurcumin.
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Export Co. Ltd., Jiangsu, China. Tetrahydrofuran, glacial acetic
acid, and hydrochloric acid were purchased from Carlo Erba,
Val de Reuil, France. Acetonitrile (HPLC grade) and methanol
(AR grade) were purchased from Burdick and Jackson, Seoul,
Korea. Ultrapure water was produced by Puris-Expe UP water
system (Model: Expe-UP Ele-M, Mirae ST Co., Ltd., Gyeonggi-
do, Korea).
2.2. Standard curcuminoid solution preparation
Stock solution of standard curcuminoids was prepared in
methanol at a concentration of 1 mg/mL. Stock solution was
diluted to six concentrations and analyzed using the HPLC
instrument (Agilent Technologies, California, USA). The cali-
bration curves of three curcuminoids were constructed.
2.3. HPLC conditions
Analysis was performed on a HPLC instrument, an Agilent
1260 series that is equipped with a photodiode array detector
and autosampler. Data analysis was performed using Open-
Lab CDS EZChrom software (Agilent Technologies, California,
USA). The isocratic separation was done on an ACE C18-PFP
column (250 mm  4.60 mm internal diameter, 5 mm)
(Advanced Chromatography Technologies Ltd., Aberdeen,
Scotland). The column temperature was controlled at 33C.
The mobile phase consisted of 2%v/v acetic acid aqueous so-
lution and acetonitrile in the ratio of 40:60 v/v with flow rate of
1 mL/min. The injection volume was 10 mL. The quantitation
wavelength was detected at 425 nm.
2.4. Method validation
2.4.1. Linearity
Stock curcuminoid solution was diluted into six concentra-
tions in methanol to obtain 0.16 mg/mL, 0.3 mg/mL, 0.6 mg/mL,
1.25 mg/mL, 2.5 mg/mL, 5.0 mg/mL, 10.0 mg/mL, and 20.0 mg/mL
calculated as 0.019e0.600 mg/mL of bisdemethoxycurcumin,
0.053e3.400 mg/mL of demethoxycurcumin, and
0.250e8.000 mg/mL of curcumin. Each concentration was per-
formed in triplicate. The standard solution was filtered
through 0.22-mm membrane filter, and then injected into the
HPLC instrument. The linear equation and R2 were reported
for each curcuminoid compound.
2.4.2. Specificity
The specificity was observed by scanned UV spectrum of
standard curcuminoids (wavelength range, 200e800 nm) in
the beginning, middle, and end of each curcuminoid peak.
Specificity was reported when the same spectrum of an indi-
vidual peak in the three regions was found. In addition, the
blank sample was injected into the HPLC instrument to
confirm the specificity.
2.4.3. Precision
The three concentration levels of three curcuminoids were
selected to study precision, both intraday and interday.
Different concentrations of curcumin were analyzed in trip-
licate: (1) 0.075 mg/mL, 0.150 mg/mL, and 0.300 mg/mL ofbisdemethoxycurcumin; (2) 0.106 mg/mL, 0.213 mg/mL, and
0.425 mg/mL of demethoxycurcumin; and (3) 0.500 mg/mL,
1.000 mg/mL, and 2.000 mg/mL. The tests, performed on the
same day and on three different days, were reported as
intraday and interday precision, respectively. The relative
standard deviation (%RSD) of each curcuminoid was reported.
2.4.4. Accuracy
The accuracy was tested using a spike method. Three curcu-
minoid concentration levels were added to known amounts of
sample solutions. Each concentration was performed in trip-
licate. The percentage recovery of each curcuminoid was
reported.
2.4.5. Limit of detection and limit of quantitation
The limit of detection (LOD) and limit of quantitation (LOQ)
were evaluated based on signal-to-noise ratio. The standard
curcuminoid solutions were diluted in methanol and injected
into the HPLC instrument. The LOQ and LOD were reported
when the signal-to-noise ratio was 10 and 3, respectively.
2.4.6. System suitability
The bisdemethoxycurcumin (0.038 mg/mL), demethox-
ycurcumin (0.213 mg/mL), and curcumin (1.000 mg/mL) solu-
tions were injected into the HPLC instrument in six replicates.
The retention time, peak area, theoretical plates, and asym-
metry were reported as mean, standard deviation, and %RSD.2.5. Determination of individual and total curcuminoid
contents
Determination of curcuminoid contents was modified from
the Thai Herbal Pharmacopoeia [8]. Briefly, turmeric powder
was removed from 10 capsules and mixed together. Turmeric
powder was weighed accurately at 300 mg, adjusted to 10 mL
by tetrahydrofuran, and then shaked at ambient temperature
for 24 hours. The supernatant was diluted 1250 times with
methanol, filtered through a 0.22-mm membrane filter, and
then injected into the HPLC instrument. Both individual and
total curcuminoid contents were calculated. All samples were
performed in triplicate.2.6. Determination of the dissolution profile of
curcuminoids from turmeric capsules
Determination of the dissolution profile of curcuminoids was
modified from the Thai Herbal Pharmacopoeia [9]. Six
turmeric capsuleswere sampled for the dissolution study. The
study was carried out using Apparatus 1 (basket apparatus;
Hanson Research Corp., California, USA.) at 100 rpm. The
dissolution medium was 0.8%w/v sodium lauryl sulfate in
0.05M hydrochloric acid (900mL) and the temperature was set
at 37C. The dissolution medium should be freshly prepare
and used within 12 hours. The dissolution medium was
sampled at 5 mL for 15 minutes, 30 minutes, 45 minutes,
60 minutes, and 90 minutes and the same volume of fresh
medium was replenished. The sampling medium was diluted
50 timeswithmethanol, filtered through a 0.22-mmmembrane
filter, and then injected into the HPLC instrument to
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of total curcuminoids was constructed.2.7. Determination of volatile oil content
Turmeric capsules were sampled for at least 20 capsules.
Turmeric powder was removed from the capsules and mixed
together. Volatile content determination was performed using
hydrodistillation following the Thai Herbal Pharmacopoeia.
Ten grams of turmeric powder was added to a 500-mL round
bottom flask and 100-mL water was added as a distillation
liquid. Distillation apparatus was connected to the round bot-
tom flask, then, a reflux condenser was inserted into the
distillation apparatus.Waterwas filled to the graduated tube of
the distillation apparatus to the standard line. The liquid was
then heated and distillation was performed for 5 hours. At a
predetermined time, the volume of volatile oil in the graduated
tube of distillation apparatus was read and recorded [10].3. Results and Discussion
This study was carried out at a low concentration of standard
curcuminoids asmentioned in the Thai Herbal Pharmacopoeia
that used UV-visible (UV-vis) spectrophotometry. UV-vis
spectrophotometry can investigate only the total concentra-
tion of curcuminoids, while HPLC can determine both indi-
vidual and total curcuminoids. Thus, HPLCwas selected in this
work. Previously, determination of curcuminoid contents
using a simple isocratic HPLC was reported [11]. The mobile
phase system consisted of 2%v/v acetic acid and acetonitrile
(60:40) at a flow rate of 2.0 mL/min, the curcuminoids were
eluted at retention time of 10.8 minutes, 12.1 minutes, andFigure 2 e High performance liquid chromatography chromatog
Hospital A dissolved in dissolution medium for 60 minutes. The
respectively. Compounds eluted at retention times of 6.0 minut
bisdemethoxycurcumin, demethoxycurcumin, and curcumin, r13.6 minutes for bisdemethoxycurcumin, demethox-
ycurcumin, andcurcumin, respectively. Theother publications
had reported an isocratic mobile phase system consisting of
acetonitrile/methanol/water (40:20:40, v/v) with a flow rate of
1 mL/min. The results showed that three curcuminoids were
eluted at retention times of 8.8 minutes, 9.5 minutes, and
10.2 minutes [12]. Furthermore, other studies showed curcu-
minoids that were separated between 10 minutes and
15 minutes [13] or > 15 minutes [14]. However, our work suc-
cessfully developed a rapid HPLC condition that took less time
to elute curcuminoids bisdemethoxycurcumin, demethox-
ycurcumin, and curcumin (retention times of 6.0 minutes,
6.7 minutes, and 7.4 minutes, respectively; Figure 2).
Linear equation, range, R2, LOD, and LOQ of individual
curcuminoids are shown in Table 1. For precision, %RSD of
bisdemethoxycurcumin, demethoxycurcumin, and curcumin
at three concentration levels was less than 2% and 5% for
intraday and interday precision, respectively. For accuracy,
the percentage recovery was 99.96e101.14%, 97.42e102.23%,
and 98.01e99.12% for bisdemethoxycurcumin, demethox-
ycurcumin, and curcumin, respectively. These results indi-
cated that this HPLC system was precise and accurate.
Precision and accuracy results of three curcuminoids are
shown in Table 2. System suitability results showed that %
RSD of all parameters were < 2%. Besides, the theoretical plate
of three curcuminoidswere > 2000, indicating that this system
was suitable (Table 3).
Determination of individual curcuminoid contents in
turmeric capsules for all nine lots from three hospitals
showed higher contents of curcumin than bisdemethox-
ycurcumin and demethoxycurcumin, and that the content of
bisdemethoxycurcumin and demethoxycurcumin were
similar. Content of curcumin, demethoxycurcumin, andram of curcuminoids from turmeric capsules produced in
blue, green, and red chromatogram indicated lot 1, 2, and 3,
es, 6.7 minutes, and 7.4 minutes were
espectively.
Table 1 e Linearity, limit of detection (LOD), and limit of quantitation (LOQ) of individual curcuminoids.
Parameters Bisdemethoxycurcumin Demethoxycurcumin Curcumin
Linear equation Y ¼ 171188 X 2136.4 Y ¼ 160600 X 3623.8 Y ¼ 164830 X 18527
Test range (mg/mL) 0.019e0.600 0.053e3.400 0.250e8.000
R2 0.9995 0.9999 0.9997
LOD (ng/mL) 2.25 1.7 3
LOQ (ng/mL) 11.25 12.75 6
Table 2 e Result of precision and accuracy studies (n ¼ 3).
Compounds Concentration (mg/mL) Precision (%RSD) Added amount
(mg/mL)
Accuracy
Intraday Interday Recovery (%)
Bisdemethoxycurcumin 0.075 1.11 1.56 0.075 101.14 ± 1.72
0.150 0.81 3.22 0.150 99.96 ± 1.31
0.300 0.51 2.20 0.300 100.79 ± 0.08
Demethoxycurcumin 0.106 0.86 3.14 0.106 100.73 ± 0.81
0.213 1.61 2.59 0.213 102.23 ± 0.77
0.425 1.67 3.62 0.425 97.42 ± 0.15
Curcumin 0.500 1.40 2.71 0.500 98.01 ± 0.65
1.000 0.64 1.40 1.000 98.51 ± 1.41
2.000 0.61 2.73 2.000 99.12 ± 0.63
Table 3 e System suitability results (n ¼ 6).
Compounds Retention time Peak area Theoretical plates (USP) Asymmetry
Bisdemethoxycurcumin (0.038 mg/mL)
Mean ± SD 6.026 ± 0.005 4181 ± 51 19719 ± 336 1.07 ± 0.02
%RSD 0.08 1.22 1.70 1.80
Demethoxycurcumin (0.213 mg/mL)
Mean ± SD 6.667 ± 0.004 30326 ± 499 17043 ± 137 1.05 ± 0.02
%RSD 0.06 1.65 0.80 1.40
Curcumin (1.000 mg/mL)
Mean ± SD 7.400 ± 0.004 144919 ± 1211 16308 ± 93 1.16 ± 0.02
%RSD 0.06 0.84 0.57 1.58
RSD ¼ relative standard deviation; SD ¼ standard deviation.
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were 6.61e7.67%w/w (average, 7.21%w/w), 2.76e3.33%w/w
(average, 3.04%w/w), and 2.64e3.47%w/w (average, 3.10%w/
w), respectively. Moreover, the total curcuminoid contents
ranged from 12.02%w/w to 14.36%w/w with an average value
of 13.35%w/w. Both intrinsic and extrinsic factors affectedTable 4 e Individual curcuminoids, total curcuminoids, and vo
Hospital Lot Bisdemethoxycurcumin
(%w/w)
Demethoxycurcu
(%w/w)
A 1 3.08 ± 0.06 3.10 ± 0.02
2 3.17 ± 0.03 3.06 ± 0.02
3 3.36 ± 0.01 3.33 ± 0.02
B 1 3.02 ± 0.04 3.06 ± 0.04
2 2.64 ± 0.01 2.76 ± 0.02
3 2.97 ± 0.02 2.96 ± 0.03
C 1 2.87 ± 0.01 2.83 ± 0.03
2 3.36 ± 0.05 3.14 ± 0.02
3 3.47 ± 0.05 3.08 ± 0.05
Average 3.10 ± 0.27 3.04 ± 0.17
The contents were reported as mean ± standard deviation (n ¼ 3).curcuminoid contents including seasonal variation, envi-
ronmental condition, postharvested handling, storage,
manufacturing, microbial contamination, etc. [15]. Thus, the
variation of curcuminoid contents in turmeric capsules was
observed in this work. The Thai Herbal Pharmacopoeia (1995)
[10] and the 2013 National List of Essential Medicineslatile oil contents.
min Curcumin
(%w/w)
Total curcuminoid
contents (%w/w)
Volatile oil
contents (%v/w)
7.35 ± 0.04 13.53 ± 0.06 8.00 ± 0.00
7.22 ± 0.03 13.45 ± 0.02 8.00 ± 0.00
7.67 ± 0.03 14.36 ± 0.05 8.00 ± 0.00
7.30 ± 0.06 13.39 ± 0.14 7.00 ± 0.00
6.61 ± 0.01 12.02 ± 0.02 7.25 ± 0.35
7.07 ± 0.03 13.00 ± 0.07 8.00 ± 0.00
6.90 ± 0.01 12.60 ± 0.04 7.00 ± 0.00
7.37 ± 0.06 13.88 ± 0.07 7.00 ± 0.00
7.39 ± 0.01 13.94 ± 0.05 7.00 ± 0.00
7.21 ± 0.31 13.35 ± 0.72 7.47 ± 0.51
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 4 9 3e4 9 9498specified total curcuminoid contents in turmeric capsules
should be higher than 5%w/w [7]. This work found that total
curcuminoid contents of all lots of turmeric capsules met the
above criteria. The individual and total curcuminoid con-
tents are shown in Table 4.Figure 3 e Dissolution profile of total curcuminoids in
turmeric capsules produced in: (A) Hospital A; (B) Hospital
B; and (C) Hospital C (n ¼ 6).Dissolution profiles of total curcuminoids in turmeric
capsules from three hospitals are shown in Figure 3. Disso-
lution of total curcuminoids showed that curcuminoids solu-
bilize well in dissolutionmedium, approximately 40e60%was
dissolved within the first 15 minutes. During the
15e90 minutes of the dissolution test, dissolution profiles
were fitted with a Higuchi model. Dissolution profiles of cur-
cuminoids were similar for all nine lots of turmeric capsules.
The Thai Herbal Pharmacopoeia (Supplement 2011) specified
that cumulative amount of total curcuminoids dissolved in
60 minutes should not be less than 75% [9]. Results showed
that cumulative amount of total curcuminoids dissolved of all
nine lots was higher than 80% in 60 minutes, indicating that
all nine lots of turmeric capsules met the criteria. However,
curcuminoids had poor water solubility and relatively poor
bioavailability, thus, solubility enhancement should be of
concern during formulation development [16].
Results of the volatile oil content of all nine lots of turmeric
capsules are shown in Table 4. The Thai Herbal Pharmaco-
poeia (1995) specified that volatile oil content should not be
less than 6%v/w [10]. The volatile oil content of all nine lots of
turmeric capsules ranged from 7.00%v/w to 8.00%v/w, indi-
cating that the volatile oil content of the nine lots of turmeric
capsules met the criteria.
We successfully validated a simple and rapid reversed
phase-HPLC for the determination of individual and total
curcuminoids in turmeric capsules. Total curcuminoid con-
tents of all lots of turmeric capsules were higher than 5%w/w.
However, the method for determination of total curcuminoid
contents was dissimilar from the Thai Herbal Pharmacopoeia
as this study used HPLC instead of UV-vis spectrophotometry.
Furthermore, dissolution profiles of curcuminoids were fitted
with Higuchi model. In addition, the volatile oil content of all
lots was higher than 6%v/w. In summary, all nine lots of
turmeric capsules from three hospitals met the standard
criteria of the Thai Herbal Pharmacopoeia in the topic of
curcuminoid contents, dissolution, and volatile oil content.Conflicts of interest
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